Pierre Dumouchel

Last updated on 2017-05-09T10:07+0300.

About this image

sign

Quotes... Extracted quotes from

Pierre Dumouchel commented ( about France and Germany ) : "Safe Group closes the third quarter of 2021 with global sales growth of 31% {excluding IFRS15 impact} compared to the first quarter of 2020. Although surgical volume has not yet returned to pre-health crisis levels, Safe Orthopaedics investments in the strategic markets of France, Germany and the US and the launch of new technologies are contributing to our growth. Safe Medical's activity has accelerated sharply since the second quarter of 2021, and it is now offering new industrial services since the qualification of its integrated production site, supporting the Group's future growth," External link

news-yahoo Thursday, October 7, 2021 7:38:00 PM EAT

Pierre Dumouchel commented ( about France and Germany ) : "Safe Group closes the third quarter of 2021 with global sales growth of 31% {excluding IFRS15 impact} compared to the first quarter of 2020. Although surgical volume has not yet returned to pre-health crisis levels, Safe Orthopaedics investments in the strategic markets of France, Germany and the US and the launch of new technologies are contributing to our growth. Safe Medical's activity has accelerated sharply since the second quarter of 2021, and it is now offering new industrial services since the qualification of its integrated production site, supporting the Group's future growth," External link

4-traders Thursday, October 7, 2021 7:05:00 PM EAT

Pierre Dumouchel explains : “Motivated by the clinical challenges expressed by surgeons, our research team is committed to finding simple and effective solutions. We are proud to announce the launch of this new technology called Sycamore and to complete our range of SteriSpine TM VA products for the management of patients with vertebral fractures” External link

AsiaOne Monday, May 24, 2021 10:46:00 AM EAT

Pierre Dumouchel explains : "Motivated by the clinical challenges expressed by surgeons, our research team is committed to finding simple and effective solutions. We are proud to announce the launch of this new technology called Sycamore and to complete our range of SteriSpine TM VA products for the management of patients with vertebral fractures" External link

finanznachrichten-en Monday, May 24, 2021 10:22:00 AM EAT

Pierre Dumouchel déclaré : "L'obtention de l'homologation de SteriSpine PS 2ème génération au États-Unis est une étape importante pour entamer notre deuxième décennie, au moment où on observe une réelle adoption des technologies prêtes-à-l'emploi à l'échelle mondiale et une compétition grandissante. Grâce aux retours de nos utilisateurs européens, nous avons conçu cette évolution plus fine, plus rigide et totalement radio-transparente pour une chirurgie mini-invasive simplifiée, répondant désormais aux attentes des chirurgiens américains " External link

capital-FR Monday, August 10, 2020 8:54:00 PM EAT

Pierre Dumouchel explained : ”2020 began with good commercial performances on a global scale with our distributors, but also with a rediscovered growth on our three direct countries (France, England and Germany). This was thanks to the restructuration of our commercial teams, initiated in 2019, and the nomination of Nikolaus Beyer as Chief Commercial Officer. Furthermore, the commercial launch of SteriSpine TM PS 2 nd Generation has already boosted our sales for the first quarter, a trend that should continue during the coming quarters, with the replacement of the stocks of direct clients and the deliveries for all our distributors” External link

4-traders Wednesday, April 8, 2020 8:02:00 PM EAT

Pierre Dumouchel said : "After the success of the SteriSpine PS launch in Japan, we are proud to announce the first results from the SteriSpine CC & LC commercial launch with our partner, KiSCO. This includes ten surgical interventions with positive feedbacks from surgeons, as expressed by Dr. Murakoshi. This is an evidence that only strengthens our ambitions for Japan, the third largest global market for spinal implant with an estimated value of €400 million," External link

4-traders Thursday, January 23, 2020 8:34:00 PM EAT

Pierre Dumouchel says : "The two approvals of SteriSpine TM LC and CC in Japan is a new step for our collaboration with KiSCO, contractualized in 2018. As from now, all our technologies within the scope of the original agreement are now available for sale and with the promising launch of SteriSpine PS, we are excited to help KiSCO in the commercial deployment of these two new ranges. As Japan is the third world's largest market sale in the spine sector, the short-term growth prospects for both companies KiSCO and Safe Orthopaedics are real," External link

finanznachrichten-en Thursday, October 24, 2019 7:17:00 PM EAT

Pierre Dumouchel says : “The two approvals of SteriSpine TM LC and CC in Japan is a new step for our collaboration with KiSCO, contractualized in 2018. As from now, all our technologies within the scope of the original agreement are now available for sale and with the promising launch of SteriSpine PS, we are excited to help KiSCO in the commercial deployment of these two new ranges. As Japan is the third world’s largest market sale in the spine sector, the short-term growth prospects for both companies KiSCO and Safe Orthopaedics are real,” External link

4-traders Thursday, October 24, 2019 7:05:00 PM EAT

Pierre Dumouchel concluded : “After leveraging the experience our engineers have gained and the feedback we have received from surgeons from the use of more than 15,000 ready-to-use spinal surgery kits, we asked a large group of surgeons to test the efficacy of our next-generation SteriSpine PS system. It represents a key growth driver and is already delivering benefits since we have recently recorded growth of 38% in Q3 2019 in the SteriSpine PS range, compared to 22% on average over the last four quarters” External link

4-traders Wednesday, October 16, 2019 6:58:00 PM EAT

Pierre Dumouchel comments : “Safe Orthopaedics recorded outstanding sales in the third quarter of 2019, at €1.159 million, with growth accelerating to 41% compared to 2018 (from 16% and 32% respectively in the first and second quarters), thanks to the promotion of our strategic fracture treatment ranges the SteriSpine PS pedicle screw and associated ready-to-use sterile instrumentation, and the SteriSpine VA vertebral augmentation balloon launched at the end of 2018 and the return to growth of our distributors and our Japanese partnership,” External link

4-traders Thursday, October 10, 2019 7:08:00 PM EAT

Pierre Dumouchel comments : "Safe Orthopaedics closed the first half of 2019 with accelerated growth in the second quarter at +32% (+16% in the first quarter) compared to 2018, thanks to the promotion of our strategic SteriSpine PS (pedicle screw combined with its ready-to-use sterile instrumentation) and SteriSpine VA (spinal augmentation balloon launched in late 2018) ranges for fracture treatment, the return to growth of distributors and our Japanese partnership," External link

finanznachrichten-en Friday, September 27, 2019 11:34:00 PM EAT

Pierre Dumouchel declared : "We thank and congratulate the Kremlin Bicêtre University Hospital team for publishing its study on our technologies in the European Journal of Orthopaedic Surgery Traumatology, the leading scientific journal in our sector. This randomized study shows an 80% reduction in pre- and post-operative duration using our technologies and offers the benefit to surgeons of having a sterile, ready-to-use technology. Helping the surgeon reduce surgical risks for the patient and enabling hospitals to reduce their costs are important issues for Safe Orthopaedics," External link

finanznachrichten-en Wednesday, September 11, 2019 8:34:00 PM EAT

Pierre Dumouchel declared : “We thank and congratulate the Kremlin Bicêtre University Hospital team for publishing its study on our technologies in the European Journal of Orthopaedic Surgery & Traumatology, the leading scientific journal in our sector. This randomized study shows an 80% reduction in pre- and post-operative duration using our technologies and offers the benefit to surgeons of having a sterile, ready-to-use technology. Helping the surgeon reduce surgical risks for the patient and enabling hospitals to reduce their costs are important issues for Safe Orthopaedics,” External link

4-traders Wednesday, September 11, 2019 8:30:00 PM EAT

Pierre Dumouchel comments : "Safe Orthopaedics is closing the first half of 2019 with accelerated growth in the second quarter that is up +32% (+16% in the first quarter) on 2018, thanks to the promotion of our strategic SteriSpine PS (pedicle screw combined with its ready-to-use sterile instrumentation) and SteriSpine VA (vertebral augmentation balloon launched at the end of 2018) ranges for fracture treatment, the return to growth among our distributors and our Japanese partnership," External link

finanznachrichten-en Wednesday, July 10, 2019 7:54:00 PM EAT

Pierre Dumouchel comments : “Safe Orthopaedics is closing the first half of 2019 with accelerated growth in the second quarter that is up +32% (+16% in the first quarter) on 2018, thanks to the promotion of our strategic SteriSpine PS (pedicle screw combined with its ready-to-use sterile instrumentation) and SteriSpine VA (vertebral augmentation balloon launched at the end of 2018) ranges for fracture treatment, the return to growth among our distributors and our Japanese partnership,” External link

4-traders Wednesday, July 10, 2019 7:51:00 PM EAT

Pierre Dumouchel comments : "Against the backdrop of unfavourable stock market conditions for small caps, this long-term financing solution offering transparency for all our investors seems the most appropriate. It will enable the company to step up its growth by means of various growth drivers, namely building up its sales teams and new products facilitating minimally invasive spine fracture surgery in order to achieve financial profitability, " External link

finanznachrichten-en Thursday, May 16, 2019 8:37:00 AM EAT

Pierre Dumouchel commented : "2018 was another year of construction for Safe Orthopaedics with the strengthening of its financial resources, the acquisition of a third direct sales force and the structuring of sales management. We also note the conquest of market share in the fracture stabilization segment, reaching 9% in the French market, and are very proud to now offer a complete range thanks to the launch of SteriSPineTM VA," External link

finanznachrichten-en Friday, April 26, 2019 8:07:00 PM EAT

Pierre Dumouchel commented : "2018 was another year of construction for Safe Orthopaedics with the strengthening of its financial resources, the acquisition of a third direct sales force and the structuring of sales management. We also note the conquest of market share in the fracture stabilization segment, reaching 9% in the French market, and are very proud to now offer a complete range thanks to the launch of SteriSPineTM VA," External link

4-traders Friday, April 26, 2019 7:59:00 PM EAT

Pierre Dumouchel commented : "2018 was another positive year in Safe Orthopaedics' development. We secured deeper financial resources, acquired a third direct sales force and reorganized our sales management through the appointment of a vice-president and country-level heads of sales. We are also pleased to report that our share of the fracture stabilization segment now stands at 9% in the French market, and we are very proud to be able to offer a full line of products following the launch of SteriSpine TM VA" External link

finanznachrichten-en Thursday, January 17, 2019 8:53:00 PM EAT

Pierre Dumouchel said : "Although our third-quarter 2016 performance in export markets was disappointing, our sales have really gained pace in areas where our marketing efforts are focused on our most highly differentiated technologies. Our products for treating trauma (SteriSpine TM PS and Oak screw) and degenerative conditions by means of a minimally invasive technique (Cypress screw) are very popular with our customers, as five surgeons recently explained in their EuroSpine presentations" External link

finanznachrichten-en Thursday, October 13, 2016 7:29:00 PM EAT



Key Titles and Phrases Count Lang Last Seen
chief executive officer69.23%EN05/09/201709/05/2017
directeur général15.38%FR04/25/201725/04/2017
pdg7.69%FR02/16/201716/02/2017
interim chief executive officer7.69%EN06/27/201627/06/2016
Names Lang Count
Pierre DumouchelEN62.50%
Pierre DumouchelFR37.50%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, December 4, 2021

4:53:00 AM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

Pierre Dumouchel

Last updated on 2017-05-09T10:07+0300.

About this image

sign

Quotes... Extracted quotes from

Pierre Dumouchel commented ( about France and Germany ) : "Safe Group closes the third quarter of 2021 with global sales growth of 31% {excluding IFRS15 impact} compared to the first quarter of 2020. Although surgical volume has not yet returned to pre-health crisis levels, Safe Orthopaedics investments in the strategic markets of France, Germany and the US and the launch of new technologies are contributing to our growth. Safe Medical's activity has accelerated sharply since the second quarter of 2021, and it is now offering new industrial services since the qualification of its integrated production site, supporting the Group's future growth," External link

news-yahoo Thursday, October 7, 2021 7:38:00 PM EAT

Pierre Dumouchel commented ( about France and Germany ) : "Safe Group closes the third quarter of 2021 with global sales growth of 31% {excluding IFRS15 impact} compared to the first quarter of 2020. Although surgical volume has not yet returned to pre-health crisis levels, Safe Orthopaedics investments in the strategic markets of France, Germany and the US and the launch of new technologies are contributing to our growth. Safe Medical's activity has accelerated sharply since the second quarter of 2021, and it is now offering new industrial services since the qualification of its integrated production site, supporting the Group's future growth," External link

4-traders Thursday, October 7, 2021 7:05:00 PM EAT

Pierre Dumouchel explains : “Motivated by the clinical challenges expressed by surgeons, our research team is committed to finding simple and effective solutions. We are proud to announce the launch of this new technology called Sycamore and to complete our range of SteriSpine TM VA products for the management of patients with vertebral fractures” External link

AsiaOne Monday, May 24, 2021 10:46:00 AM EAT

Pierre Dumouchel explains : "Motivated by the clinical challenges expressed by surgeons, our research team is committed to finding simple and effective solutions. We are proud to announce the launch of this new technology called Sycamore and to complete our range of SteriSpine TM VA products for the management of patients with vertebral fractures" External link

finanznachrichten-en Monday, May 24, 2021 10:22:00 AM EAT

Pierre Dumouchel déclaré : "L'obtention de l'homologation de SteriSpine PS 2ème génération au États-Unis est une étape importante pour entamer notre deuxième décennie, au moment où on observe une réelle adoption des technologies prêtes-à-l'emploi à l'échelle mondiale et une compétition grandissante. Grâce aux retours de nos utilisateurs européens, nous avons conçu cette évolution plus fine, plus rigide et totalement radio-transparente pour une chirurgie mini-invasive simplifiée, répondant désormais aux attentes des chirurgiens américains " External link

capital-FR Monday, August 10, 2020 8:54:00 PM EAT

Pierre Dumouchel explained : ”2020 began with good commercial performances on a global scale with our distributors, but also with a rediscovered growth on our three direct countries (France, England and Germany). This was thanks to the restructuration of our commercial teams, initiated in 2019, and the nomination of Nikolaus Beyer as Chief Commercial Officer. Furthermore, the commercial launch of SteriSpine TM PS 2 nd Generation has already boosted our sales for the first quarter, a trend that should continue during the coming quarters, with the replacement of the stocks of direct clients and the deliveries for all our distributors” External link

4-traders Wednesday, April 8, 2020 8:02:00 PM EAT

Pierre Dumouchel said : "After the success of the SteriSpine PS launch in Japan, we are proud to announce the first results from the SteriSpine CC & LC commercial launch with our partner, KiSCO. This includes ten surgical interventions with positive feedbacks from surgeons, as expressed by Dr. Murakoshi. This is an evidence that only strengthens our ambitions for Japan, the third largest global market for spinal implant with an estimated value of €400 million," External link

4-traders Thursday, January 23, 2020 8:34:00 PM EAT

Pierre Dumouchel says : "The two approvals of SteriSpine TM LC and CC in Japan is a new step for our collaboration with KiSCO, contractualized in 2018. As from now, all our technologies within the scope of the original agreement are now available for sale and with the promising launch of SteriSpine PS, we are excited to help KiSCO in the commercial deployment of these two new ranges. As Japan is the third world's largest market sale in the spine sector, the short-term growth prospects for both companies KiSCO and Safe Orthopaedics are real," External link

finanznachrichten-en Thursday, October 24, 2019 7:17:00 PM EAT

Pierre Dumouchel says : “The two approvals of SteriSpine TM LC and CC in Japan is a new step for our collaboration with KiSCO, contractualized in 2018. As from now, all our technologies within the scope of the original agreement are now available for sale and with the promising launch of SteriSpine PS, we are excited to help KiSCO in the commercial deployment of these two new ranges. As Japan is the third world’s largest market sale in the spine sector, the short-term growth prospects for both companies KiSCO and Safe Orthopaedics are real,” External link

4-traders Thursday, October 24, 2019 7:05:00 PM EAT

Pierre Dumouchel concluded : “After leveraging the experience our engineers have gained and the feedback we have received from surgeons from the use of more than 15,000 ready-to-use spinal surgery kits, we asked a large group of surgeons to test the efficacy of our next-generation SteriSpine PS system. It represents a key growth driver and is already delivering benefits since we have recently recorded growth of 38% in Q3 2019 in the SteriSpine PS range, compared to 22% on average over the last four quarters” External link

4-traders Wednesday, October 16, 2019 6:58:00 PM EAT

Pierre Dumouchel comments : “Safe Orthopaedics recorded outstanding sales in the third quarter of 2019, at €1.159 million, with growth accelerating to 41% compared to 2018 (from 16% and 32% respectively in the first and second quarters), thanks to the promotion of our strategic fracture treatment ranges the SteriSpine PS pedicle screw and associated ready-to-use sterile instrumentation, and the SteriSpine VA vertebral augmentation balloon launched at the end of 2018 and the return to growth of our distributors and our Japanese partnership,” External link

4-traders Thursday, October 10, 2019 7:08:00 PM EAT

Pierre Dumouchel comments : "Safe Orthopaedics closed the first half of 2019 with accelerated growth in the second quarter at +32% (+16% in the first quarter) compared to 2018, thanks to the promotion of our strategic SteriSpine PS (pedicle screw combined with its ready-to-use sterile instrumentation) and SteriSpine VA (spinal augmentation balloon launched in late 2018) ranges for fracture treatment, the return to growth of distributors and our Japanese partnership," External link

finanznachrichten-en Friday, September 27, 2019 11:34:00 PM EAT

Pierre Dumouchel declared : "We thank and congratulate the Kremlin Bicêtre University Hospital team for publishing its study on our technologies in the European Journal of Orthopaedic Surgery Traumatology, the leading scientific journal in our sector. This randomized study shows an 80% reduction in pre- and post-operative duration using our technologies and offers the benefit to surgeons of having a sterile, ready-to-use technology. Helping the surgeon reduce surgical risks for the patient and enabling hospitals to reduce their costs are important issues for Safe Orthopaedics," External link

finanznachrichten-en Wednesday, September 11, 2019 8:34:00 PM EAT

Pierre Dumouchel declared : “We thank and congratulate the Kremlin Bicêtre University Hospital team for publishing its study on our technologies in the European Journal of Orthopaedic Surgery & Traumatology, the leading scientific journal in our sector. This randomized study shows an 80% reduction in pre- and post-operative duration using our technologies and offers the benefit to surgeons of having a sterile, ready-to-use technology. Helping the surgeon reduce surgical risks for the patient and enabling hospitals to reduce their costs are important issues for Safe Orthopaedics,” External link

4-traders Wednesday, September 11, 2019 8:30:00 PM EAT

Pierre Dumouchel comments : "Safe Orthopaedics is closing the first half of 2019 with accelerated growth in the second quarter that is up +32% (+16% in the first quarter) on 2018, thanks to the promotion of our strategic SteriSpine PS (pedicle screw combined with its ready-to-use sterile instrumentation) and SteriSpine VA (vertebral augmentation balloon launched at the end of 2018) ranges for fracture treatment, the return to growth among our distributors and our Japanese partnership," External link

finanznachrichten-en Wednesday, July 10, 2019 7:54:00 PM EAT

Pierre Dumouchel comments : “Safe Orthopaedics is closing the first half of 2019 with accelerated growth in the second quarter that is up +32% (+16% in the first quarter) on 2018, thanks to the promotion of our strategic SteriSpine PS (pedicle screw combined with its ready-to-use sterile instrumentation) and SteriSpine VA (vertebral augmentation balloon launched at the end of 2018) ranges for fracture treatment, the return to growth among our distributors and our Japanese partnership,” External link

4-traders Wednesday, July 10, 2019 7:51:00 PM EAT

Pierre Dumouchel comments : "Against the backdrop of unfavourable stock market conditions for small caps, this long-term financing solution offering transparency for all our investors seems the most appropriate. It will enable the company to step up its growth by means of various growth drivers, namely building up its sales teams and new products facilitating minimally invasive spine fracture surgery in order to achieve financial profitability, " External link

finanznachrichten-en Thursday, May 16, 2019 8:37:00 AM EAT

Pierre Dumouchel commented : "2018 was another year of construction for Safe Orthopaedics with the strengthening of its financial resources, the acquisition of a third direct sales force and the structuring of sales management. We also note the conquest of market share in the fracture stabilization segment, reaching 9% in the French market, and are very proud to now offer a complete range thanks to the launch of SteriSPineTM VA," External link

finanznachrichten-en Friday, April 26, 2019 8:07:00 PM EAT

Pierre Dumouchel commented : "2018 was another year of construction for Safe Orthopaedics with the strengthening of its financial resources, the acquisition of a third direct sales force and the structuring of sales management. We also note the conquest of market share in the fracture stabilization segment, reaching 9% in the French market, and are very proud to now offer a complete range thanks to the launch of SteriSPineTM VA," External link

4-traders Friday, April 26, 2019 7:59:00 PM EAT

Pierre Dumouchel commented : "2018 was another positive year in Safe Orthopaedics' development. We secured deeper financial resources, acquired a third direct sales force and reorganized our sales management through the appointment of a vice-president and country-level heads of sales. We are also pleased to report that our share of the fracture stabilization segment now stands at 9% in the French market, and we are very proud to be able to offer a full line of products following the launch of SteriSpine TM VA" External link

finanznachrichten-en Thursday, January 17, 2019 8:53:00 PM EAT

Pierre Dumouchel said : "Although our third-quarter 2016 performance in export markets was disappointing, our sales have really gained pace in areas where our marketing efforts are focused on our most highly differentiated technologies. Our products for treating trauma (SteriSpine TM PS and Oak screw) and degenerative conditions by means of a minimally invasive technique (Cypress screw) are very popular with our customers, as five surgeons recently explained in their EuroSpine presentations" External link

finanznachrichten-en Thursday, October 13, 2016 7:29:00 PM EAT



Key Titles and Phrases Count Lang Last Seen
chief executive officer69.23%EN05/09/201709/05/2017
directeur général15.38%FR04/25/201725/04/2017
pdg7.69%FR02/16/201716/02/2017
interim chief executive officer7.69%EN06/27/201627/06/2016
Names Lang Count
Pierre DumouchelEN62.50%
Pierre DumouchelFR37.50%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, December 4, 2021

4:53:00 AM EAT


Quotes... Explore Relations


EMM Visual Explorer